Content |
2024: Sales of smart patches in the world rose to $9.95 billion at the end of the year
In 2024, spending on the global smart patch market reached $9.95 billion. More than a third of sales in monetary terms were in the North American region. Such data are provided in a study by Grand View Research, the results of which Zdrav.Expert reviewed in mid-May 2025.
The sector in question is showing steady growth driven by advances in medical technology and increasing demand for remote monitoring of patients. Smart patches can contain sensors to track different measures of the body's health, such as glucose levels, heart rate and body temperature. The data collected can be transmitted to the attending physician or analyzed for dangerous deviations from the established values. Such products are convenient to use and do not create discomfort for patients. Smart patches can also be used to deliver medicines to the human body.
A significant market driver is the increasing prevalence of chronic diseases including diabetes and atrial fibrillation. As the population ages, health problems become more common, which stimulates the demand for health control products. Smart patches can also be used in the field of personalized medicine. The transmitted indicators help in building the optimal treatment regimen that provides the best results.
Technological advances as well as the introduction of artificial intelligence play an important role in expanding the industry. As an example, the authors of the study cite a smart ultrasonic patch developed by scientists at the University of California, San Diego: this product allows continuous non-invasive monitoring of the blood supply to the brain in order to identify signs of stroke. At the same time, AI algorithms serve to detect a variety of diseases early, including cardiovascular diseases. With the help of neural networks, medical institutions can effectively analyze patient data, identifying dangerous deviations that may indicate the development of certain ailments. In addition, AI makes it possible to form individual treatment plans taking into account the current state of a person and the characteristics of his body.
In general, analysts emphasize, the smart patch industry demonstrates a high degree of innovation due to advances in AI, flexible electronics and biosensory technologies. Such products improve the management of chronic diseases, remote monitoring of patients and the provision of medical services.
From a geographical point of view, North America is the leader in terms of sales of smart patches, which in 2024 accounted for 36% of revenue, or $3.58 billion was estimated: the dominance of the region is due to the high level of development of healthcare infrastructure and the introduction of advanced developments in the field of medicine. Globally, significant players are named:
- AliveCor;
- VivaLNK;
- Cardiac Insight;
- VitalConnect;
- LifeSignals;
- Dexcom;
- Gentag;
- Abbott Laboratories;
- Koninklijke Philips N.V.;
- Sensium Healthcare;
- Leaf Healthcare;
- Qualcomm Technologies.
In 2025, spending on smart patches worldwide is expected to reach $10.64 billion. Analysts at Grand View Research believe that in the future, the CAGR in the market under consideration will be 8.1%. As a result, by 2030, costs will rise to $15.71 billion.[1]
2017: Skyrocketing - 36 times by 2022
Analysts at research firm Tractica expect the smart patch market to skyrocket. The forecast, published in mid-November 2017, stipulates that their deliveries will increase by more than 36 times by 2022.
Experts attribute smart patches to the segment of wearable electronics and explain that this term refers to a wide list of solutions that are attached to the skin: from transdermal patches to tattoos applied to the skin and small devices that provide wireless communication and various functions related to medicine and health. The purposes of their use can range from tracking a person's physiological parameters and diagnosis to administering medical drugs, treating and preventing diseases.
An example is a "smart" medical bandage, trials of which are planned at the Institute of Life Sciences at Swansea University in the UK. With built-in nanosensors and support for 5G networks, it will be able to promptly inform the doctor about how the wound is healing, BBC News reported in April 2017.
Tractica experts see great prospects in this direction. In 2016, deliveries of the first such products began, and in 2017 about 966 thousand smart patches will be released. In the future, as awareness of such decisions by the medical community and patients grows, the supply of smart patches will reach 35.1 million by 2022, and revenue in this market will approach $8 billion. Experts note that approximately 80% of smart patches produced will have a clinical purpose.
 | The smart patch market is still in its early stages of development and commercial adoption, but this is a promising direction that can improve patient health and reduce healthcare costs, "commented Tractica analyst Sherril Hanson on the study[2] |  |
See also
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |